product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
Anti-mouse IgG, AP-linked Antibody
catalog :
7056
conjugate :
nonconjugated
reactivity :
human
application :
western blot
more info or order :
Cell Signaling Technology product webpage
citations: 9
Published Application/Species/Sample/DilutionReference
  • western blot; human; loading ...; fig s3b
Zhang J, MacArtney T, Peggie M, Cohen P. Interleukin-1 and TRAF6-dependent activation of TAK1 in the absence of TAB2 and TAB3. Biochem J. 2017;474:2235-2248 pubmed publisher
Wills P, Anjana M, Nitin M, Varun R, Sachidanandan P, Jacob T, et al. Population Explosions of Tiger Moth Lead to Lepidopterism Mimicking Infectious Fever Outbreaks. PLoS ONE. 2016;11:e0152787 pubmed publisher
Sakata R, Kabutomori R, Okano K, Mitsui H, Takemura A, Miwa T, et al. Rhodopsin in the Dark Hot Sea: Molecular Analysis of Rhodopsin in a Snailfish, Careproctus rhodomelas, Living near the Deep-Sea Hydrothermal Vent. PLoS ONE. 2015;10:e0135888 pubmed publisher
Artero Castro A, Perez Alea M, Feliciano A, Leal J, Genestar M, Castellvi J, et al. Disruption of the ribosomal P complex leads to stress-induced autophagy. Autophagy. 2015;11:1499-519 pubmed publisher
Toda R, Okano K, Takeuchi Y, Yamauchi C, Fukushiro M, Takemura A, et al. Hypothalamic expression and moonlight-independent changes of Cry3 and Per4 implicate their roles in lunar clock oscillators of the lunar-responsive Goldlined spinefoot. PLoS ONE. 2014;9:e109119 pubmed publisher
Stengel C, Newman S, Day J, Chander S, Jourdan F, Leese M, et al. In vivo and in vitro properties of STX2484: a novel non-steroidal anti-cancer compound active in taxane-resistant breast cancer. Br J Cancer. 2014;111:300-8 pubmed publisher
Lei F, Song J, Haque R, Haque M, Xiong X, Fang D, et al. Regulation of A1 by OX40 contributes to CD8(+) T cell survival and anti-tumor activity. PLoS ONE. 2013;8:e70635 pubmed publisher
Haque R, Lei F, Xiong X, Wu Y, Song J. FoxP3 and Bcl-xL cooperatively promote regulatory T cell persistence and prevention of arthritis development. Arthritis Res Ther. 2010;12:R66 pubmed publisher
Stengel C, Newman S, Leese M, Potter B, Reed M, Purohit A. Class III beta-tubulin expression and in vitro resistance to microtubule targeting agents. Br J Cancer. 2010;102:316-24 pubmed publisher
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.